G. Hassall

Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation.

Jon Winter, David Whittaker, Gareth Davies, 2012, Journal of medicinal chemistry.

Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.

A. Parker, D. Hargreaves, R. Pauptit, 2007, Journal of molecular biology.

Inhibition of pig aortic smooth muscle cell DNA synthesis by selective type III and type IV cyclic AMP phosphodiesterase inhibitors.

G. Hassall, J. Souness, D. P. Parrott, 1992, Biochemical pharmacology.

Purification and characterization of endogenous peptides extracted from HLA‐DR isolated from the spleen of a patient with rheumatoid arthritis

Paul Wordsworth, S. Rayner, R. Gordon, 1995, European journal of immunology.

Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives

J. Nissink, J. Tucker, M. McAlister, 2012, PloS one.

Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation.

N. Turner, G. Hassall, C. M. Carter, 1991, Biochemical pharmacology.

Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.

R. Gordon, R. Hockney, S. Powell, 1993, Molecular pharmacology.